SCHEMBL18909116

SCHEMBL18909116

CCC(=O)N1CCC(N(C)CCC(=O)N2CCC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
EPHX2 P34913 2/20 0.43
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
HSD11B1 P28845 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPY5R Q15761 2/20 0.38
TP53 P04637 1/20 0.38
ACKR3 P25106 1/20 0.38
GNAI3 P08754 1/20 0.37
GNAO1 P09471 1/20 0.37
GNAI1 P63096 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281128 0.84 EPHX2 (0.49) EPHX2MEN1KMT2ANPY5RALDH1A1
SCHEMBL22030495 0.84 NPC1 (0.41) NPC1ATML3MBTL1HSD11B1MEN1
SCHEMBL21281206 0.84 NPC1 (0.41) NPC1ATML3MBTL1HSD11B1KMT2A
SCHEMBL19275282 0.84 EPHX2 (0.44) NPC1EPHX2NPY5RGNAI3GNAO1
SCHEMBL18909244 0.81 EPHX2 (0.49) EPHX2ATML3MBTL1MEN1KMT2A
SCHEMBL18909336 0.78 EPHX2 (0.39) EPHX2NPY5RALDH1A1
SCHEMBL12516865 0.77 L3MBTL3 (0.53) NPC1EPHX2L3MBTL1NPY5RALDH1A1
SCHEMBL18909233 0.77 EPHX2 (0.38) EPHX2NPY5RALDH1A1
SCHEMBL25923427 0.77 EPHX2 (0.42) NPC1EPHX2NPY5RGNAI3GNAO1
SCHEMBL11948184 0.76 ATM (0.52) NPC1ATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed